Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Phase I trial assesses interaction between diabetes therapies

March 20, 2012

Novel hedgehog pathway activators divulged by Fate Therapeutics

March 19, 2012

Novel somatostatin sst5 receptor antagonists developed

March 19, 2012

Medivir to file application for phase I trials of bone disorder candidate

March 19, 2012

Shionogi & Co. divulges novel potential obesity drugs

March 16, 2012

Studies demonstrate various therapeutic applications for SEH inhibition

March 16, 2012

First oral contraceptive for heavy menstrual bleeding approved in U.S.

March 15, 2012

Shire withdraws BLA for Fabry's disease therapy

March 15, 2012

Amgen reports new myostatin-binding antibodies

March 15, 2012

Alkermes Pharma Ireland withdraws megestrol MAA

March 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...